SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immucor
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: technetx who wrote (1)10/8/1997 7:08:00 AM
From: Jim Cash  Read Replies (1) of 422
 
I've been following this company for quite some time... Back in 92, Value Line OTC Special Situatons had a write up on BLUD with a 3-5 year target of 53 based upon their ABS 2000 machine. The machine was delayed a bit and now it seems that they are set for approval within a 30 - 60 day timeframe. The company has stated that they have 400 indications to purchase the ABS 2000 in the United States. Even if they do not come close to closing all 400 indications , at appr 90 K per pop and the reagent trail that follows, we are on to something very big here. The beauty with this issue is that they only have a float of 8 million shares so it won't take alot to give them a very nice EPS figure and couple this with the fact that it trades between 30 and 40 times earnings and the math adds up to a healthy share price.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News